Futibatinib
Back to searchMolecule Structure
Scientific Name
Futibatinib
Description of the Drug
Futibatinib is a kinase inhibitor used to treat intrahepatic cholangiocarcinoma in previously treated adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15149
http://www.drugbank.ca/drugs/DB15149
Brand Name(s)
Lytgobi
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Fibroblast growth factor receptor | PROTEIN FAMILY | INHIBITOR | CHEMBL2095217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15345470 |
| DrugBank | DB15149 |
| PubChem | 71621331 |
| PDBe | TZ0 |
| BindingDB | 161389 |
| ChemicalBook | CB03155059 |
| Guide to Pharmacology | 9786 |
| ZINC | ZINC000207800318 |
